Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.

Gao Smith F, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, Khan Z, Lamb SE; BALTI-2 study investigators.

Lancet. 2012 Jan 21;379(9812):229-35. doi: 10.1016/S0140-6736(11)61623-1. Epub 2011 Dec 11.

PMID:
22166903
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.

Gates S, Perkins GD, Lamb SE, Kelly C, Thickett DR, Young JD, McAuley DF, Snaith C, McCabe C, Hulme CT, Gao Smith F.

Health Technol Assess. 2013 Sep;17(38):v-vi, 1-87. doi: 10.3310/hta17380.

PMID:
24028755
[PubMed - indexed for MEDLINE]
Free Article
3.

Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome.

Perkins GD, Gates S, Lamb SE, McCabe C, Young D, Gao F.

Trials. 2011 May 9;12:113. doi: 10.1186/1745-6215-12-113.

PMID:
21554679
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial.

Perkins GD, McAuley DF, Thickett DR, Gao F.

Am J Respir Crit Care Med. 2006 Feb 1;173(3):281-7. Epub 2005 Oct 27.

PMID:
16254268
[PubMed - indexed for MEDLINE]
5.

Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.

Needham CJ, Brindley PG.

Can J Anaesth. 2012 Jan;59(1):105-8. doi: 10.1007/s12630-011-9615-2. Epub 2011 Nov 1.

PMID:
22042702
[PubMed]
6.

The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.

Bellingan G, Maksimow M, Howell DC, Stotz M, Beale R, Beatty M, Walsh T, Binning A, Davidson A, Kuper M, Shah S, Cooper J, Waris M, Yegutkin GG, Jalkanen J, Salmi M, Piippo I, Jalkanen M, Montgomery H, Jalkanen S.

Lancet Respir Med. 2014 Feb;2(2):98-107. doi: 10.1016/S2213-2600(13)70259-5. Epub 2013 Dec 23.

PMID:
24503265
[PubMed - indexed for MEDLINE]
7.

Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.

Abraham E, Baughman R, Fletcher E, Heard S, Lamberti J, Levy H, Nelson L, Rumbak M, Steingrub J, Taylor J, Park YC, Hynds JM, Freitag J.

Crit Care Med. 1999 Aug;27(8):1478-85.

PMID:
10470753
[PubMed - indexed for MEDLINE]
8.

Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.

Travers AH, Milan SJ, Jones AP, Camargo CA Jr, Rowe BH.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD010179. doi: 10.1002/14651858.CD010179. Review.

PMID:
23235685
[PubMed - indexed for MEDLINE]
9.

Neuromuscular blockers in early acute respiratory distress syndrome.

Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Guérin C, Prat G, Morange S, Roch A; ACURASYS Study Investigators.

N Engl J Med. 2010 Sep 16;363(12):1107-16. doi: 10.1056/NEJMoa1005372.

PMID:
20843245
[PubMed - indexed for MEDLINE]
Free Article
10.

First do no harm: surrogate endpoints and the lesson of β-agonists in acute lung injury.

Lakshminarayana PH, Kahn JM.

Crit Care. 2012 Jun 26;16(3):314. [Epub ahead of print]

PMID:
22731873
[PubMed - as supplied by publisher]
Free PMC Article
11.

Randomised trial of intravenous salbutamol in early management of acute severe asthma in children.

Browne GJ, Penna AS, Phung X, Soo M.

Lancet. 1997 Feb 1;349(9048):301-5.

PMID:
9024371
[PubMed - indexed for MEDLINE]
12.

Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial.

Dorhout Mees SM, Algra A, Vandertop WP, van Kooten F, Kuijsten HA, Boiten J, van Oostenbrugge RJ, Al-Shahi Salman R, Lavados PM, Rinkel GJ, van den Bergh WM; MASH-2 Study Group.

Lancet. 2012 Jul 7;380(9836):44-9. doi: 10.1016/S0140-6736(12)60724-7. Epub 2012 May 25. Erratum in: Lancet. 2012 Jul 7;380(9836):28. Lancet. 2012 Dec 8;380(9858)1994. MASH-2 Study Group [added]; Boiten, J [added]; Kerklaan, J [added]; Dennesen, P J W [added].

PMID:
22633825
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.

Zajicek J, Ball S, Wright D, Vickery J, Nunn A, Miller D, Gomez Cano M, McManus D, Mallik S, Hobart J; CUPID investigator group.

Lancet Neurol. 2013 Sep;12(9):857-65. doi: 10.1016/S1474-4422(13)70159-5. Epub 2013 Jul 13. Review.

PMID:
23856559
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.

Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis K Jr, Hyers TM, Papadakos P.

Crit Care Med. 1998 Jan;26(1):15-23.

PMID:
9428538
[PubMed - indexed for MEDLINE]
15.

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial.

Dodel R, Rominger A, Bartenstein P, Barkhof F, Blennow K, Förster S, Winter Y, Bach JP, Popp J, Alferink J, Wiltfang J, Buerger K, Otto M, Antuono P, Jacoby M, Richter R, Stevens J, Melamed I, Goldstein J, Haag S, Wietek S, Farlow M, Jessen F.

Lancet Neurol. 2013 Mar;12(3):233-43. doi: 10.1016/S1474-4422(13)70014-0. Epub 2013 Jan 31.

PMID:
23375965
[PubMed - indexed for MEDLINE]
16.

B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial.

VITATOPS Trial Study Group.

Lancet Neurol. 2010 Sep;9(9):855-65. doi: 10.1016/S1474-4422(10)70187-3. Epub 2010 Aug 3.

PMID:
20688574
[PubMed - indexed for MEDLINE]
Free Article
17.

Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.

National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Matthay MA, Brower RG, Carson S, Douglas IS, Eisner M, Hite D, Holets S, Kallet RH, Liu KD, MacIntyre N, Moss M, Schoenfeld D, Steingrub J, Thompson BT.

Am J Respir Crit Care Med. 2011 Sep 1;184(5):561-8. doi: 10.1164/rccm.201012-2090OC.

PMID:
21562125
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.

Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA.

JAMA. 1998 Jul 8;280(2):159-65.

PMID:
9669790
[PubMed - indexed for MEDLINE]
19.

Intravenous salbutamol in ARDS and increased mortality.

Abroug F, Besbes LO, Ouanes I, Dachraoui F.

Lancet. 2012 May 19;379(9829):1875; author reply 1876. doi: 10.1016/S0140-6736(12)60805-8. No abstract available.

PMID:
22608332
[PubMed - indexed for MEDLINE]
20.

Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome.

O'Kane CM, McKeown SW, Perkins GD, Bassford CR, Gao F, Thickett DR, McAuley DF.

Crit Care Med. 2009 Jul;37(7):2242-9. doi: 10.1097/CCM.0b013e3181a5506c.

PMID:
19487934
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk